SERACARE
LIVE

Serial Number

77832375

Owner

LGC CLINICAL DIAGNOSTICS, INC.

Attorney

Mainak H. Mehta

First Use Date

Sep 26, 2001

Filing Date

Sep 22, 2009

Add to watchlist:

No watchlists yet
View on USPTO

SERACARE Trademark

Serial Number: 77832375 • Registration: 4451588

SERACARE is a trademark filed by LGC CLINICAL DIAGNOSTICS, INC. on September 22, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

LGC CLINICAL DIAGNOSTICS, INC. (11 trademarks)

37 BIRCH STREET
MILFORD, MA 01757

Entity Type: 03

SERACARE LIFE SCIENCES, INC. (28 trademarks)

37 BIRCH STREET
MILFORD, MA 01757

Entity Type: 03

Trademark Details

Filing Date

September 22, 2009

Registration Date

December 17, 2013

First Use Anywhere

September 26, 2001

First Use in Commerce

September 26, 2001

Published for Opposition

August 30, 2011

Goods & Services

Diagnostic reagents for medical and veterinary use; Clinical medical reagents; Diagnostic chemicals, reagents or preparations for medical and veterinary use; Chemical reagents for medical and veterinary use; Chemical reagents for pharmaceutical purposes and use in the pharmaceutical industry, namely, chemical reagents for use as diluents and excipients; Testing reagents for medical or clinical use; Genetic testing controls for the testing of human serum, infectious disease antibodies and antigens, and viral nucleic acids, namely, medical diagnostic reagents and assays; Chemical reference materials, namely, quality controls and panels in the nature of human compounds for medical or veterinary use; Chemical reference specimens, namely, serological, viral, genetic and nucleic acid reference specimens in the nature of human serum, infectious disease antibodies and antigens for medical or veterinary use

Diagnostic chemicals, reagents or preparations for scientific, research or manufacturing use in chemical, pharmaceutical and biotechnology industries; Diagnostic reagents for clinical, medical laboratory or manufacturing use in chemical, pharmaceutical and biotechnology industries; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry, microbiology; Reagents and tools, namely, animal serums, bovine serum albumin, and human blood products, namely, plasma, serum, cells, and human serum albumin, and chromogenic substrates, all for research purposes or manufacturing use in chemical, pharmaceutical and biotechnology industries; Chemical reagents other than for medical or veterinary purposes; Chemical preparations for scientific purposes; Chemical ingredients for use as exipients or diluents in the manufacture of pharmaceuticals; Chemical reagents for reference control, namely, genetic testing controls and controls for the testing of human serum, infectious disease antibodies and antigens, and viral nucleic acids, all for industrial use and not for medical purposes; Chemical solutions in the nature of quality control standard solutions for testing human serum, infectious disease antibodies and antigens, human genetics, and viral nucleic acids, all for industrial use and not for medical purposes; Chemical control serum for scientific or research use in the nature of quality controls for infectious disease and genetic testing; Biochemical control serum for scientific or research use in the nature of quality controls for infectious disease and genetic testing; Biochemical standard serum for scientific or research use; Quality control standard solutions and quality control materials for testing and calibrating medical apparatus and reagents for scientific and research purposes and for clinical or medical laboratory use; Standard serum, control serum, biochemical standard serum, biochemical control serum for scientific and research purposes and for clinical or medical laboratory use

Custom design and development of chemical reagents and biochemical assays; Providing reagent sample testing for others in the fields of, science and research related thereto; Research support services in the nature of assay development and validation, product development, and report generation, all in the fields of virology, immunological, biological and biochemical research

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 21, 2024 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 21, 2024 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Feb 21, 2024 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 21, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 26, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 17, 2022 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 5, 2022 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 10, 2020 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 10, 2020 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 10, 2020 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 12, 2020 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 17, 2018 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2013 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 13, 2013 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Nov 12, 2013 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 11, 2013 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 6, 2013 SUPC
USE AMENDMENT FILED
Oct 24, 2013 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 24, 2013 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2013 EXRA
SOU EXTENSION 3 GRANTED
May 1, 2013 EX3G
SOU EXTENSION 3 FILED
Apr 25, 2013 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 25, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2012 EXRA
SOU EXTENSION 2 GRANTED
Oct 30, 2012 EX2G
SOU EXTENSION 2 FILED
Oct 25, 2012 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 25, 2012 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2012 EXRA
SOU EXTENSION 1 GRANTED
May 16, 2012 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 16, 2012 AITU
SOU EXTENSION 1 FILED
Apr 25, 2012 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 25, 2012 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 25, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 30, 2011 NPUB
PUBLISHED FOR OPPOSITION
Aug 30, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 26, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 20, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 19, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 18, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 18, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 18, 2011 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 23, 2011 GNRN
NON-FINAL ACTION E-MAILED
Mar 23, 2011 GNRT
NON-FINAL ACTION WRITTEN
Mar 23, 2011 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 15, 2011 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 28, 2011 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 17, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 1, 2011 TROA
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Feb 1, 2011 CEPE
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 31, 2011 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 31, 2011 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jan 31, 2011 CPEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 13, 2010 TCCA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 29, 2010 GNFN
FINAL REFUSAL E-MAILED
Jul 29, 2010 GNFR
FINAL REFUSAL WRITTEN
Jul 29, 2010 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2010 CRFA
ASSIGNED TO LIE
Jul 9, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2009 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2009 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2009 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2009 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2009 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2009 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2009 DOCK
NOTICE OF PSEUDO MARK MAILED
Sep 26, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2009 NWOS
NEW APPLICATION ENTERED
Sep 25, 2009 NWAP